TEVA 5907 TEVA 5907 (Mesalamine Delayed-Release 400 mg)

Pill with imprint TEVA 5907 TEVA 5907 is Clear, Capsule-shape and has been identified as Mesalamine Delayed-Release 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis, active; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5907 TEVA 5907

Mesalamine Delayed-Release

Imprint: TEVA 5907 TEVA 5907
Strength: 400 mg
Color: Clear
Shape: Capsule-shape
Availability: Prescription only
Drug Class: 5-aminosalicylates
Pregnancy Category: B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC): 00093-5907